Stevanato Group S.P.A. (STVN) Stock Price, Quote & News

Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delive...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 39 04 99 31 811

Website: www.stevanatogroup.com

Address:

Via Molinella 17, Piombino Dese, Italy

SuperGreenToday May. 18 at 8:51 PM

$STVN Share Price: $17.80 Contract Selected: Dec 18, 2026 $20 Calls Buy Zone: $0.34 – $0.42 Target Zone: $0.58 – $0.71 Potential Upside: 61% ROI Time to Expiration: 213 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

StocktwitsEarnings May. 7 at 12:27 PM

$STVN Q1 '26 Earnings Results & Recap Stevanato Group maintains its fiscal 2026 guidance, expecting revenue between 1.26B and 1.29B, adjusted EBITDA from 331.8M to 346.9M, and adjusted diluted EPS in the range of 0.59 to 0.63.

0 · Reply

Turokk Mar. 4 at 9:21 PM

$ALP it will start going up + positive news coming out the 13th after the meeting. $ASNS $STVN $XPON

2 · Reply

OpenOutcrier Mar. 4 at 1:43 PM

$STVN (+8.6% pre) Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins https://ooc.bz/l/95453

0 · Reply

StocktwitsEarnings Mar. 4 at 1:27 PM

$STVN Q4 '25 Earnings Results & Recap Stevanato Group expects fiscal 2026 revenue between 1.26B and 1.29B, adjusted EBITDA from 331.8M to 346.9M, and adjusted diluted EPS in the range of 0.59 to 0.63.

0 · Reply

SuperGreenToday Feb. 12 at 8:07 PM

$STVN Share Price: $15.67 Contract Selected: Sep 18, 2026 $15 Calls Buy Zone: $0.77 – $0.95 Target Zone: $1.33 – $1.62 Potential Upside: 64% ROI Time to Expiration: 217 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

WellTodd Jan. 26 at 3:45 PM

$STVN what’s going on with this pos. Did it just have a big shake out or are we going lower still.

0 · Reply

Arcides Jan. 23 at 7:50 PM

$STVN flushing....high volume

0 · Reply

BillionerOfKing Jan. 6 at 5:22 PM

$STVN Current Stock Price: $21.36 Contracts to trade: $22.5 STVN Jan 16 2026 Call Entry: $1.29 Exit: $2.33 ROI: 81% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

BillionerOfKing Dec. 5 at 8:53 PM

$STVN Current Stock Price: $22.00 Contracts to trade: $20 STVN Dec 19 2025 Call Entry: $5.40 Exit: $10.14 ROI: 88% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Stevanato Group Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 5:45 PM EDT - 1 day ago

Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders' Meeting

Jun 2, 2026, 3:40 PM EDT - 2 days ago

Stevanato Group Transcript: 46th Annual William Blair Growth Stock Conference

2026-06-01T20:39:26.000Z - 3 days ago

Stevanato Group assumed with an Outperform at Wolfe Research

Jun 1, 2026, 7:00 AM EDT - 3 days ago

Stevanato Group Slides: Investor presentation

May 12, 2026, 11:00 AM EDT - 23 days ago

Stevanato Group Transcript: Bank of America Global Healthcare Conference 2026

May 7, 2026, 8:30 AM EDT - 4 weeks ago

Stevanato Group Earnings Call Transcript: Q1 2026

May 7, 2026, 8:30 AM EDT - 4 weeks ago

Stevanato Group Earnings release: Q1 2026

May 7, 2026, 8:30 AM EDT - 4 weeks ago

Stevanato Group Slides: Q1 2026

May 7, 2026, 6:30 AM EDT - 4 weeks ago

Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026

May 4, 2026, 5:45 PM EDT - 4 weeks ago

Stevanato Group to Participate in Three Upcoming Investor Conferences

Apr 23, 2026, 4:05 PM EDT - 6 weeks ago

Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026

2026-03-23T17:30:57.000Z - 2 months ago

Stevanato Group management to meet with KeyBanc

Mar 21, 2026, 7:00 AM EDT - 2 months ago

Stevanato Group Slides: Investor presentation

Mar 17, 2026, 9:45 AM EDT - 2 months ago

Stevanato Group Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

Mar 12, 2026, 4:45 PM EDT - 3 months ago

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

2026-03-06T13:27:03.000Z - 3 months ago

Stevanato Group price target lowered to $19 from $24 at Morgan Stanley

2026-03-05T11:44:31.000Z - 3 months ago

Stevanato Group price target lowered to $32 from $37 at KeyBanc

2026-03-05T11:40:04.000Z - 3 months ago

Stevanato Group price target lowered to $26 from $32 at Citi

2026-03-04T18:40:13.000Z - 3 months ago

Stevanato Group price target lowered to $28 from $30 at BofA

Mar 4, 2026, 8:30 AM EST - 3 months ago

Stevanato Group Earnings Call Transcript: Q4 2025

Mar 4, 2026, 8:30 AM EST - 3 months ago

Stevanato Group Annual report: Q4 2025

Mar 4, 2026, 8:30 AM EST - 3 months ago

Stevanato Group Earnings release: Q4 2025

Mar 4, 2026, 8:30 AM EST - 3 months ago

Stevanato Group Slides: Q4 2025

Mar 4, 2026, 6:30 AM EST - 3 months ago

Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins

Feb 19, 2026, 6:30 AM EST - 3 months ago

Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026

2026-02-10T14:15:58.000Z - 4 months ago

Stevanato Group price target lowered to $17.50 from $23 at Jefferies

2025-12-01T21:35:23.000Z - 6 months ago

Stevanato Group assumed with an Equal Weight at Morgan Stanley

Nov 24, 2025, 7:00 AM EST - 6 months ago

Stevanato Group Slides: Investor presentation

Nov 19, 2025, 6:00 AM EST - 7 months ago

Stevanato Group Transcript: Jefferies London Healthcare Conference 2025

Nov 17, 2025, 8:40 AM EST - 7 months ago

Stevanato Group Transcript: Wolfe Research Healthcare Conference 2025

2025-11-11T13:06:18.000Z - 7 months ago

Stevanato Group price target raised to $26 from $24 at Morgan Stanley

Nov 6, 2025, 8:30 AM EST - 7 months ago

Stevanato Group Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 7 months ago

Stevanato Group Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 7 months ago

Stevanato Group Slides: Q3 2025

2025-11-06T12:00:56.000Z - 7 months ago

Stevanato Group reports Q3 adjusted EPS EUR0.14 vs. EUR0.12 last year

2025-11-06T12:00:33.000Z - 7 months ago

Stevanato Group sees 2025 adjusted EPS EUR0.50-EUR0.54

Nov 6, 2025, 6:30 AM EST - 7 months ago

Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025

Oct 31, 2025, 7:30 AM EDT - 7 months ago

Stevanato Group to Participate in Upcoming Investor Conferences

Oct 22, 2025, 6:30 AM EDT - 8 months ago

Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025

2025-10-21T10:46:26.000Z - 8 months ago

Stevanato Group expands drug delivery system manufacturing capacity

Oct 21, 2025, 6:30 AM EDT - 8 months ago

Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings

Sep 24, 2025, 5:45 AM EDT - 9 months ago

Stevanato Group Transcript: Bank of America Global Healthcare Conference 2025

Sep 9, 2025, 7:45 AM EDT - 9 months ago

Stevanato Group Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 5, 2025, 8:30 AM EDT - 10 months ago

Stevanato Group Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 10 months ago

Stevanato Group Earnings release: Q2 2025

Aug 5, 2025, 8:30 AM EDT - 10 months ago

Stevanato Group Slides: Q2 2025

Aug 5, 2025, 6:30 AM EDT - 10 months ago

Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025

Jul 23, 2025, 6:30 AM EDT - 11 months ago

Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.

Jul 22, 2025, 4:30 PM EDT - 11 months ago

Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025

Jun 5, 2025, 10:30 AM EDT - 1 year ago

Stevanato Group Transcript: Jefferies Global Healthcare Conference 2025

Jun 4, 2025, 2:20 PM EDT - 1 year ago

Stevanato Group Transcript: 45th Annual William Blair Growth Stock Conference

May 8, 2025, 8:30 AM EDT - 1 year ago

Stevanato Group Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Stevanato Group Earnings release: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Stevanato Group Slides: Q1 2025

May 8, 2025, 6:37 AM EDT - 1 year ago

Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025

Apr 24, 2025, 5:15 PM EDT - 1 year ago

Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025

2025-04-21T12:00:48.000Z - 1 year ago

Stevanato Group resumed with an Overweight at Stephens

Mar 18, 2025, 3:00 PM EDT - 1 year ago

Stevanato Group Transcript: KeyBanc Annual Healthcare Forum 2025

2025-03-17T17:55:32.000Z - 1 year ago

Stevanato Group management to meet with Stephens

Mar 6, 2025, 8:30 AM EST - 1 year ago

Stevanato Group Earnings Call Transcript: Q4 2024

Mar 6, 2025, 8:30 AM EST - 1 year ago

Stevanato Group Annual report: Q4 2024

Mar 6, 2025, 8:30 AM EST - 1 year ago

Stevanato Group Earnings release: Q4 2024

Mar 6, 2025, 8:30 AM EST - 1 year ago

Stevanato Group Slides: Q4 2024

Mar 6, 2025, 6:31 AM EST - 1 year ago

Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024

Feb 24, 2025, 4:02 PM EST - 1 year ago

Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025

Jan 14, 2025, 8:00 AM EST - 1 year ago

Stevanato Group Transcript: CJS Securities 25th Annual “New Ideas for the New Year” Investor Conference

Jan 7, 2025, 4:30 PM EST - 1 year ago

Stevanato Group to Present at Upcoming Investor Conference

2024-12-13T13:16:18.000Z - 1 year ago

Stevanato Group price target raised to $26 from $24 at BofA

2024-12-13T11:45:29.000Z - 1 year ago

Wolfe starts Stevanato with Outperform on return to growth

2024-12-13T11:01:18.000Z - 1 year ago

Stevanato Group initiated with an Outperform at Wolfe Research

Dec 3, 2024, 1:45 PM EST - 1 year ago

Stevanato Group Transcript: Citi's 2024 Global Healthcare Conference

2024-12-03T12:55:07.000Z - 1 year ago

Stevanato Group assumed with an Equal Weight at Morgan Stanley

Nov 19, 2024, 4:00 AM EST - 1 year ago

Stevanato Group Transcript: Jefferies London Healthcare Conference 2024

Nov 12, 2024, 2:00 PM EST - 1 year ago

Stevanato Group Transcript: UBS Global Healthcare Conference 2024

Nov 11, 2024, 6:32 AM EST - 1 year ago

Stevanato Group to Present at Upcoming Investor Conferences

2024-11-06T14:00:44.000Z - 1 year ago

Stevanato Group price target raised to $24 from $23 at UBS

Nov 5, 2024, 8:30 AM EST - 1 year ago

Stevanato Group Earnings Call Transcript: Q3 2024

Nov 5, 2024, 8:30 AM EST - 1 year ago

Stevanato Group Earnings release: Q3 2024

Nov 5, 2024, 8:30 AM EST - 1 year ago

Stevanato Group Slides: Q3 2024

Nov 5, 2024, 6:31 AM EST - 1 year ago

Stevanato Group Reports Financial Results for the Third Quarter of 2024

Oct 22, 2024, 4:30 PM EDT - 1 year ago

Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024

Oct 1, 2024, 6:30 AM EDT - 1 year ago

Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan

Sep 26, 2024, 7:04 AM EDT - 1 year ago

Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”

Sep 18, 2024, 9:10 AM EDT - 1 year ago

Stevanato Group Transcript: Bank of America Global Healthcare Conference 2024

Sep 6, 2024, 7:00 AM EDT - 1 year ago

Stevanato Group Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 6, 2024, 8:30 AM EDT - 1 year ago

Stevanato Group Earnings Call Transcript: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 1 year ago

Stevanato Group Earnings release: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 1 year ago

Stevanato Group Slides: Q2 2024

Aug 6, 2024, 6:31 AM EDT - 1 year ago

Stevanato Group Reports Financial Results for the Second Quarter of 2024

Jul 25, 2024, 6:30 AM EDT - 2 years ago

Stevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 1, 2024, 7:30 AM EDT - 2 years ago

Stevanato Being Investigated on Behalf of Stevanato Group S.p.A. Investors.

Jun 11, 2024, 7:30 AM EDT - 2 years ago

An Investigation Has Commenced on Behalf of Stevanato Group S.p.A. Shareholders.

Jun 6, 2024, 9:30 AM EDT - 2 years ago

Stevanato Group Transcript: Jefferies Global Healthcare Conference

Jun 4, 2024, 5:00 PM EDT - 2 years ago

Stevanato Group Transcript: The 44th Annual William Blair Growth Stock Conference

May 30, 2024, 5:00 AM EDT - 2 years ago

Stevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and Cartridges

May 28, 2024, 7:00 AM EDT - 2 years ago

Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro

May 24, 2024, 4:10 PM EDT - 2 years ago

Stevanato Group Announces Results of Annual General Meeting

May 15, 2024, 2:20 PM EDT - 2 years ago

Stevanato Group Transcript: BofA Securities 2024 Health Care Conference

May 9, 2024, 8:30 AM EDT - 2 years ago

Stevanato Group Earnings Call Transcript: Q1 2024

May 9, 2024, 8:30 AM EDT - 2 years ago

Stevanato Group Earnings release: Q1 2024

May 9, 2024, 8:30 AM EDT - 2 years ago

Stevanato Group Slides: Q1 2024

May 9, 2024, 6:39 AM EDT - 2 years ago

Stevanato Group Reports Financial Results for the First Quarter of 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Stevanato Group to Present at the Bank of America Securities Healthcare Conference

SuperGreenToday May. 18 at 8:51 PM

0 · Reply

StocktwitsEarnings May. 7 at 12:27 PM

0 · Reply

Turokk Mar. 4 at 9:21 PM

$ALP it will start going up + positive news coming out the 13th after the meeting. $ASNS $STVN $XPON

2 · Reply

OpenOutcrier Mar. 4 at 1:43 PM

0 · Reply

StocktwitsEarnings Mar. 4 at 1:27 PM

0 · Reply

SuperGreenToday Feb. 12 at 8:07 PM

0 · Reply

WellTodd Jan. 26 at 3:45 PM

$STVN what’s going on with this pos. Did it just have a big shake out or are we going lower still.

0 · Reply

Arcides Jan. 23 at 7:50 PM

$STVN flushing....high volume

0 · Reply

BillionerOfKing Jan. 6 at 5:22 PM

0 · Reply

BillionerOfKing Dec. 5 at 8:53 PM

0 · Reply

JarvisFlow Dec. 2 at 5:56 PM

Morgan Stanley updates rating for Stevanato Group ( $STVN ) to Equal-Weight, target set at 26 → 24.

0 · Reply

JarvisFlow Nov. 11 at 4:56 PM

Morgan Stanley has updated their rating for Stevanato Group ( $STVN ) to Equal-Weight with a price target of 26.

0 · Reply

Findingthebull Oct. 7 at 3:41 PM

$STVN Added here. Will see if I timed it right.

0 · Reply

NVDAMillionaire Sep. 29 at 6:02 AM

$STVN Excellent article that nails exactly where STVN stands right now. So if you want to update your STVN knowledge or get acquainted with STVN, this is a must read. https://beyondspx.com/quote/STVN/analysis/stevanato-group-precision-expansion-and-biologics-drive-growth-nyse-stvn

0 · Reply

SteepDescent_ Aug. 20 at 10:03 PM

$STVN Last post from July. It's time to change that. under the radar for now but.. cleared all gates with margin (predicate_chain 0.74, link_pred 0.84, liquidity OK, financing OK) and matched the anchor theme. Evidence fit: timed RTU-cartridge adds for 2025–26 + clear GLP-1 pen overlap → clean predicate chain; plausible LTAs in 6–18 m. speculative buy 24m horizon, with p50 ≈2.1× and p90 ≈5.3×. Short window compresses upside.

0 · Reply

W15E Jul. 25 at 12:51 PM

$STVN has been a bit of a steady eddy

0 · Reply

W15E Jul. 11 at 1:50 AM

$STVN adding a bit more

0 · Reply

Market Cap	5.69B
Revenue (ttm)	1.34B
Net Income (ttm)	158.21M
EPS (ttm)	N/A
PE Ratio	30.31
Forward PE	27.47
Profit Margin	11.79%
Debt to Equity Ratio	0.30

Volume	182,600
Avg Vol	525,144
Day's Range	N/A - N/A
Shares Out	302.84M
Stochastic %K	45%
Beta	0.78
Analysts	Strong Sell
Price Target	$24.31